Search
Sumario de resultados
TIpos de contenido
Fecha
-
-
-
Press releaseORYZON receives approval to start PORTICO Phase IIb trial with vafidemstat in Borderline P...
Clinical Trial Application approved by Spanish Drug Agency
-
EventSpringer Nature panel discussion: AI, Ethics, and your Business
Springer’s new journal, AI and Ethics seeks to promote informed debate and discussion of the ethical, regulatory, and policy implications that arise from the development of AI
-
EventUK-Spain Covid-19 Vaccines Roundtable
The British Embassy in Madrid and the Consulate General in Barcelona organize this bilateral session, which will bring together key players to discuss current and future
-
Offer
Postdoctoral Position
-
EventStart at the End: What to Show the Regulators?
Johnson & Johnson Innovation – JLABS brings you a program with learnings that may help you smooth your regulatory approach.
-
EventColorize the Blueprint for your Biologics Clinical Trial Application
Johnson & Johnson Innovation – JLABS invites you to an in-depth look into CMC strategies and clinical trial design
-
EventGlobal Innovation 2021 Ayming barometer: COVID-19 and beyond
Discover some exclusive insights from Ayming’s second edition of the International Innovation Barometer during our webinar, takin place on 12th November 2020.
-
Press release
Oryzon announces appointment of Dr. Torsten Hoffmann as Global R&D Director and retirement...
At Roche, Dr. Hoffmann was Head of Discovery Chemistry and Head of the Roche Postdoc Fellowship Program. Subsequently he served as Chief Scientific Officer and Executive VP at Zealand Pharma, Chief
-
EventBioeconomy Communication and Stakeholders, engagement in times of COVID-19
Workshop organised by the European Bioeconomy Network
-
Press release
BHV Partners settles in the Barcelona Science Park and closes a 500,000 euros investment r...
In just over a year of history, the company has established itself as a leading driver in the biomedical innovation and entrepreneurship scene
-
EventAseBio Green Innovation Forum
Organized by AseBio, the Spanish Bioindustry Association, the event aims to highlight this recovery agenda that encourages and renews Spain’s commitment to science and innovation
-
Press release
Oryzon Reports Results for Quarter Ended September 30
Oryzon Genomics reported financial results for the third quarter of 2020 and provided an update on recent developments
-
EventNature Cancer: How Scientific Research Supports Your Business
Your researchers are empowered to push your organization ahead of the competition
-
Press release
Asphalion joins Barcelona Health Hub to boost technological and digital innovation in the ...
“New technologies are a key element of digital transformation in the healthcare sector", Ricard Sagués, Business Development & Marketing Director at Asphalion
-
Press release
SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Office...
New investors include 4BIO Capital, UPMC Enterprises, Jeito Capital and Ysios Capital
-
Press release
ORYZON holds its 4th annual Solidarity Day
The OSD is an annual initiative whereby the company's employees devote part of their working hours to carry out activities that can have a positive impact on society
-
Event
AseBio Green Innovation Forum 2020
A digital event organized by AseBio, in a collaboration with the Biotechnology Markets Platform-Ministry of Science, Innovation and Universities and the Institute of
-
Press release
ORYZON publishes paper in Journal of Clinical Oncology demonstrating relevance of iadadems...
Paper describes mechanism of differentiation in patients and first antileukemic responses
-
EventInvest in USA / Doing Business in the USA: Illinois, New Jersey, South Caroline y Virginia
With the participation of the Ambassador of the United States to Spain, Mr. Duke Buchan III as well as the President of the Spain Chamber of Commerce, Mr.